Xana Smart Neurostimulation

Xana is a MedTech company that specializes in developing non-invasive and intelligent neurostimulation systems for treating various neurological conditions, including insomnia, chronic pain, depression, anxiety, and stroke. The company has patented a unique wearable and miniaturized technology that stimulates the vagus nerve, coupled with a cloud system to collect physiological data for assessing treatment efficacy and personalization.

Xana's technology aims to modulate abnormal electrical neural signals present in a wide range of disorders, such as anxiety, mood disorders, chronic pain, cardiovascular diseases, age-related memory impairment, and neuronal degeneration. Conventional pharmacological treatments for these conditions often lack desired efficiency and safety. In contrast, Xana's medical devices for brain stimulation emerge as a powerful therapeutic tool poised to revolutionize the treatment of brain diseases.

Existing devices for modulating brain activity have significant drawbacks, including invasiveness, limited usability due to size constraints, and lack of treatment personalization, hindering clinical effectiveness and patient acceptance. Xana has demonstrated the ability to transform cutting-edge microelectronics to create wireless, highly miniaturized, and low-power devices, leading to reduced risk, shorter recovery times, and better patient acceptance.

Xana leverages digital technologies to personalize treatments and provide objective data on therapy efficacy. Monitoring the delivered stimulation dose and its real-time effect on the body enables the creation of unique neuromodulation systems. The company has developed and validated its proprietary algorithm to measure the impact of stimulation on cardiovascular function, which, combined with other physiological indices like oxygen saturation and respiratory rate, offers physicians an exceptional tool for diagnosis, efficacy assessment, and treatment adherence.